Emergence of Reduced Susceptibility and Resistance to Fluoroquinolones in Escherichia coli in Taiwan and Contributions of Distinct Selective Pressures
Open Access
- 1 November 2001
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 45 (11) , 3084-3091
- https://doi.org/10.1128/aac.45.11.3084-3091.2001
Abstract
A survey of 1,203 Escherichia coli isolates from 44 hospitals in Taiwan revealed that 136 (11.3%) isolates were resistant to fluoroquinolones and that another 261 (21.7%) isolates had reduced susceptibility. Resistance was more common in isolates responsible for hospital-acquired (mostly in intensive care units) infections (17.5%) than in other adult inpatient (11.4%; P = 0.08) and outpatient isolates (11.9%; P > 0.1). Similarly, reduced susceptibility was more common in isolates responsible for hospital-acquired infections (30.9%) than in other adult inpatient (21.0%; P = 0.04) and outpatient (21.4%; P = 0.06) isolates. Isolates from pediatric patients were less likely to be resistant (1.3 versus 12.0%; P < 0.01) but were nearly as likely to have reduced susceptibility (17.7 versus 21.9%; P > 0.1) as nonpediatric isolates. There was an inverse relationship in the proportion of isolates that were resistant versus the proportion that had reduced susceptibility among isolates from individual hospitals ( R = 0.031; P < 0.05). In an analysis of isolates from two hospitals, all 9 resistant strains possessed double point mutations in gyrA and all 19 strains with reduced susceptibility strains had single point mutations; no mutations were found among fully susceptible strains. Risk factors for resistance included underlying cancer (odds ratio [OR], 83; 95% confidence interval [CI 95 ], 7.3 to 2,241; P < 0.001), exposure to a quinolone (OR, undefined; P = 0.02), and exposure to a nonquinolone antibiotic (OR, 20; CI 95 , 2.2 to 482; P < 0.001); underlying cancer was the only independent risk factor (OR, 83; CI 95 , 8.6 to 807; P < 0.001). There were no significant associations between any of these factors and reduced susceptibility. Whereas acute and chronic quinolone use in cancer patients is a major selective pressure for resistance, other undetermined but distinct selective pressures appear to be more responsible for reduced susceptibility to fluoroquinolones in E. coli .Keywords
This publication has 36 references indexed in Scilit:
- An Outbreak of Multidrug-Resistant, Quinolone-ResistantSalmonella entericaSerotype Typhimurium DT104New England Journal of Medicine, 1999
- Mechanisms of Fluoroquinolone Resistance: An Update 1994-1998Drugs, 1999
- Quinolone‐ResistantSalmonella typhiin Viet Nam: Molecular Basis of Resistance and Clinical Response to TreatmentClinical Infectious Diseases, 1997
- Molecular Epidemiological Analysis of Quinolone‐ResistantEscherichia coliCausing Bacteremia in Neutropenic Patients with Leukemia in KoreaClinical Infectious Diseases, 1997
- Ciprofloxacin-resistant Escherichia coli emerging in a rehabilitation medical centerDiagnostic Microbiology and Infectious Disease, 1997
- gyrA Mutations in high-level fluoroquinolone-resistant clinical isolates of Escherichia coliJournal of Antimicrobial Chemotherapy, 1996
- Emergence of Quinolone-Resistant Escherichia coli Bacteremia in Neutropenic Patients with Cancer Who Have Received Prophylactic NorfloxacinClinical Infectious Diseases, 1995
- Epidemiology of Quinolone ResistanceDrugs, 1995
- Risk Factors for Acquisition of Urinary Tract Infections Caused by Ciprofloxacin Resistant Escherichia ColiJournal of Urology, 1995
- CDC definitions for nosocomial infections, 1988American Journal of Infection Control, 1988